Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data

Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological malignancies, including B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (ALL). The treatment is currently also being...

Descripción completa

Detalles Bibliográficos
Autores principales: Roex, Gils, Feys, Tom, Beguin, Yves, Kerre, Tessa, Poiré, Xavier, Lewalle, Philippe, Vandenberghe, Peter, Bron, Dominique, Anguille, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076393/
https://www.ncbi.nlm.nih.gov/pubmed/32102267
http://dx.doi.org/10.3390/pharmaceutics12020194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076393/
https://www.ncbi.nlm.nih.gov/pubmed/32102267
http://dx.doi.org/10.3390/pharmaceutics12020194

Ejemplares similares